While patients with glioma that harbour a mutation in the isocitrate dehydrogenase (IDH)‐1 gene were found to be at very low risk of VTE,3, 4 intratumoral expression of the sialomucin‐like glycoprotein podoplanin was found as a major risk factor for VTE.5 This evidence concerns the gene PDPN and glioma.